Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Cequa™ in Subjects With Dry Eye Disease That Is Currently Inadequately Controlled While on Cyclosporine 0.05% Ophthalmic Emulsion

NCT04357795 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.

NCT NCT04357795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04357795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Cequa™ in Subjects With Dry Eye Disease That Is Currently Inadequately Controlled While on Cyclosporine 0.05% Ophthalmic Emulsion
Lead sponsor
Sun Pharmaceutical Industries Limited
Phase
Phase 4
Overall status
Completed
Start date
June 29, 2020
Completion date
June 24, 2022
Enrollment
135 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease